NEUCA S.A. (WSE:NEU)

Market Cap	3.54B
Revenue (ttm)	13.04B
Net Income (ttm)	135.42M
Shares Out	4.48M
EPS (ttm)	29.76
PE Ratio	26.55
Forward PE	20.45
Dividend	16.00 (2.03%)
Ex-Dividend Date	Jul 15, 2025

Volume	724
Average Volume	1,346
Open	798.00
Previous Close	798.00
Day's Range	780.00 - 798.00
52-Week Range	636.00 - 900.00
Beta	0.49
RSI	63.20
Earnings Date	Nov 14, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.